MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Science

• Publication date

  1993-09-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.7690157PMID 7690157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

  1993cited by this paper
• Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor β chain from a myelin basic protein‐specific T cell clone

  1993cited by this paper
• Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis.

  1993cited by this paper
• Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.

  1993cited by this paper
• The cognitive principle challenges clonal selection.

  1992cited by this paper
• Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity

  1992cited by this paper
• T cell vaccination in multiple sclerosis: a preliminary report.

  1992cited by this paper
• Autoreactive T cells in multiple sclerosis.

  1992cited by this paper
• Immunological aspects of demyelinating diseases.

  1992cited by this paper
• Mechanisms of resistance to autoimmune disease induced by T-cell vaccination.

  1991cited by this paper
• T cells responsive to myelin basic protein in patients with multiple sclerosis.

  1990cited by this paper
• T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

  1990cited by this paper
• Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.

  1989cited by this paper
• Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

  1989cited by this paper
• Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.

  1988cited by this paper
• Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T–T cell interactions

  1988cited by this paper
• T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination

  1985cited by this paper
• Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.

  1985cited by this paper
• Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response.

  1984cited by this paper
• A human suppressor T cell clone which recognizes an autologous helper T cell clone

  1982cited by this paper
• The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

  1981cited by this paper
• Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

  1981cited by this paper

• Therapeutic immune tolerance for central nervous system autoimmune diseases - Prospects, challenges and pitfalls.

  2026cites this paper
• Engineered cell entry links receptor biology with single-cell genomics.

  2022cites this paper
• Immunosenescence in multiple sclerosis: The identification of new therapeutic targets.

  2021cites this paper
• Harnessing CD8+CD28− Regulatory T Cells as a Tool to Treat Autoimmune Disease

  2021cites this paper
• Active and Passive Immunization with Myelin Basic Protein as a Method for Early Treatment of Traumatic Spinal Cord Injury; a Meta-Analysis

  2021cites this paper
• Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy

  2021cites this paper
• Antigen-Specific Immune Tolerance in Multiple Sclerosis—Promising Approaches and How to Bring Them to Patients

  2021cites this paper
• Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective

  2020influential citation
• Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020

  2020cites this paper
• CD8+ T cells: The past and future of immune regulation.

  2020cites this paper
• Distinct PLZF+CD8αα+ Unconventional T Cells Enriched in Liver Use a Cytotoxic Mechanism to Limit Autoimmunity

  2019cites this paper
• Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases.

  2018cites this paper
• Description of CD8+ Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer

  2018cites this paper
• T Cells in Multiple Sclerosis + Cytotoxic CD8 Therapeutic Induction of Regulatory,

  2017cites this paper
• High throughput autoantigen discovery in the spondyloarthropathies and the development of a CFSE based killing assay

  2017cites this paper
• Multiple Sclerosis

  2016cites this paper
• Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications

  2015cites this paper
• Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma

  2015cites this paper
• Role of T cell—glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms

  2015cites this paper
• Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells

  2014cites this paper
• Antigen-specific tolerization approaches in multiple sclerosis

  2014cites this paper
• Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis

  2014cites this paper
• Activation of benign autoimmunity as both tumor and autoimmune disease immunotherapy: a comprehensive review.

  2014cites this paper
• The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review

  2014cites this paper
• This information is current as Encephalomyelitis Experimental Autoimmune Targeting of Encephalitogenic CD 4 T Cells in Autoregulatory CD 8 T Cells Is Mediated by The Disease-Ameliorating Function of Karandikar

  2013cites this paper
• The Disease-Ameliorating Function of Autoregulatory CD8 T Cells Is Mediated by Targeting of Encephalitogenic CD4 T Cells in Experimental Autoimmune Encephalomyelitis

  2013cites this paper
• This information is current as Encephalomyelitis Experimental Autoimmune Targeting of Encephalitogenic CD 4 T Cells in Autoregulatory CD 8 T Cells Is Mediated by The Disease-Ameliorating Function of Karandikar

  2013cites this paper
• Pillars article: High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 1994. 78: 399-408.

  2013cites this paper
• Immunotherapy of Multiple Sclerosis

  2013cites this paper
• Peptide of Myelin Basic Protein in Multiple Cells Recognizing an Immunodominant 13.1 T β A Common TCR V-D-J Sequence in V

  2013cites this paper
• Autologous T-Cell Vaccination for Multiple Sclerosis

  2012cites this paper
• Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients : A Randomized , Double-Blind Clinical Trial

  2012cites this paper
• REGULATORY CD4+ AND CD8+ T CELLS AS CANDIDATES FOR REGENERATIVE THERAPIES IN A MOUSE MODEL OF MULTIPLE SCLEROSIS

  2012cites this paper
• Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus

  2012cites this paper
• Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models

  2012cites this paper
• T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial

  2012cites this paper
• Mechanisms of demyelination and axonal damage in a CD8+ T cell-mediated model of spontaneous demyelinating disease

  2010cites this paper
• Serum cell adhesion molecules in patients with colorectal cancer

  2010cites this paper
• Studies of Immune Regulation in Type 1 Diabetes

  2010cites this paper
• Acquisition of regulatory function by human CD8+ T cells treated with anti‐CD3 antibody requires TNF

  2010cites this paper
• T cells in experimental autoimmune encephalomyelitis

  2010cites this paper
• Exploring the roles of CD8+ T lymphocytes in the pathogenesis of autoimmune demyelination

  2010cites this paper
• Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis.

  2010cites this paper
• T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells.

  2010cites this paper
• CD8α+ dendritic cells prime TCR‐peptide‐reactive regulatory CD4+FOXP3− T cells

  2010cites this paper
• Autoimmune T cell responses in the central nervous system

  2009cites this paper
• Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

  2009cites this paper
• T‐cell seeding: neonatal transfer of anti‐myelin basic protein T‐cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis

  2009cites this paper
• Clone clusters in autoreactive CD4 T‐cell lines from probable multiple sclerosis patients form disease‐characteristic signatures

  2009cites this paper
• Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.

  2009cites this paper
• Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis.

  2009influential citation
• Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis

  2009cites this paper
• Therapeutic vaccines for autoimmune Diseases

  2009cites this paper
• Immune Suppression by a Novel Population of CD8ββ+TCRββ+ Regulatory T cells

  2008cites this paper
• Zukünftige Therapien der multiplen Sklerose

  2008cites this paper
• Antigen-specific therapies in MS - Current concepts and novel approaches.

  2008cites this paper
• Autologous T-cell vaccination for multiple sclerosis: a perspective on progress.

  2008cites this paper
• The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.

  2008cites this paper
• Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosis.

  2008cites this paper
• Can the immune system be harnessed to repair the CNS?

  2008cites this paper
• Revival of CD8+ Treg-mediated suppression.

  2008cites this paper
• Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

  2008cites this paper
• HSP 60 as a Target of Anti-Ergotypic Regulatory T Cells

  2008cites this paper
• Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3gamma1 (Ala-Ala).

  2008cites this paper
• Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.

  2008cites this paper
• Induction of Adaptive CD4+CD25+Foxp3+ Regulatory T Cell Response in Autoimmune Disease

  2008cites this paper
• Impact of Psoralen/UVA-Treatment on Survival, Activation, and Immunostimulatory Capacity of Monocyte-Derived Dendritic Cells

  2008cites this paper
• HSP60 as a Target of Anti-Ergotypic Regulatory T Cells

  2008cites this paper
• Vaccines for Multiple Sclerosis

  2008cites this paper
• Humanized Chimeric Receptors in the Therapy of Multiple Sclerosis

  2007cites this paper
• Vaccination with selected synovial T cells in rheumatoid arthritis.

  2007cites this paper
• CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE

  2007cites this paper
• Emerging therapies for MS.

  2007cites this paper
• T cell-based therapies in multiple sclerosis

  2007cites this paper
• Treatment of autoimmune disease: time for a paradigm shift?

  2007cites this paper
• Anti-Inflammatory Properties and Regulatory Mechanism of a Novel Derivative of Artemisinin in Experimental Autoimmune Encephalomyelitis1

  2007cites this paper
• Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

  2007cites this paper
• Anti-Inflammatory Properties and Regulatory Mechanism of a Novel Derivative of Artemisinin in Experimental Autoimmune Encephalomyelitis

  2007cites this paper
• Maintenance of antigen‐specific immunological memory through variable regions of heavy and light chains of anti‐idiotypic antibody

  2007cites this paper
• T Cell Vaccination in Autoimmune Disease

  2007cites this paper
• The Immunological Basis for Treatment of Multiple Sclerosis

  2007cites this paper
• Therapeutic Induction of Regulatory, Cytotoxic CD8+ T Cells in Multiple Sclerosis1

  2006cites this paper
• CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis.

  2006cites this paper
• Booster immunization of antigen primed mice with anti-idiotypic T cells generates antigen-specific memory T cell response.

  2006cites this paper
• Role of T-cell receptor V beta 8.3 peptide vaccine in the prevention of experimental autoimmune uveoretinitis.

  2006influential citation
• Translating the Concept of Suppressor/Regulatory T Cells to Clinical Applications

  2006cites this paper
• T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination

  2006cites this paper
• Regulation of Immunity by a Novel Population of Qa-1-Restricted CD8αα+TCRαβ+ T Cells1

  2006cites this paper
• Activated mouse T cells downregulate, process and present their surface TCR to cognate anti‐idiotypic CD4+ T cells

  2006cites this paper
• G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: a possible mechanism for exacerbation of multiple sclerosis.

  2006cites this paper
• T Cells + βα TCR + αα Population of Qa-1-Restricted CD 8 Regulation of Immunity by a Novel and Vipin

  2006cites this paper
• Specific control of immunity by regulatory CD8 T cells.

  2005influential citation
• Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis

  2005cites this paper
• Future Therapies for Multiple Sclerosis

  2005cites this paper
• T cell vaccination in systemic lupus erythematosus with autologous activated T cells

  2005cites this paper
• Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention

  2005cites this paper
• Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis.

  2005cites this paper
• Regulatory T Cells in Autoimmune Diseases: Anti-Ergotypic T Cells

  2005cites this paper
• Unique Gene Expression Patterns in Human T-cell Lines Generated from Multiple Sclerosis Patients by Stimulation with a Synthetic MOG Peptide

  2005influential citation
• Antigen-Specific Therapies in Multiple Sclerosis

  2005cites this paper